Accelrys, Inc. (NASDAQ:ACCL), a leading scientific enterprise R&D software and services company, is pleased to announce that Chr. Hansen has selected the on-premise iLabber electronic lab notebook (ELN) from Accelrys’ wholly-owned subsidiary Contur for global knowledge management across the enterprise. The iLabber notebook (previously the ConturELN) is a proven, cost-effective, server-based system that improves process documentation, information sharing and reuse, IP protection and overall productivity for leading biotechnology, chemical and food and beverage companies, as well as universities.
“We chose the iLabber system because it met our high quality requirements for a global deployment,” said Dr. Morten Meldgaard, project director of Chr. Hansen’s ELN project. “Of all the products we assessed, iLabber scored highest overall in simplicity and ease-of-use; out-of-the-box fit with current IT platforms; and low total cost-of-ownership with minimal training required.”
“Chr. Hansen’s selection of iLabber confirms the benefits of the notebook’s flexible, out-of-the-box capabilities and turnkey ease-of-deployment,” said Thomas Rozlucki, managing director of Contur, a wholly-owned subsidiary of Accelrys. “The global ELN roll-out at Chr. Hansen is a reflection of iLabber’s continuing rapid adoption and deployment in the food and beverage industry.”
Chr. Hansen is a leading supplier of natural colors and bacterial cultures for the food industry. With 2,300 employees and application centers in more than 20 countries, the company initiated an aggressive ELN rollout requiring full deployment within two years. A pilot study with 60 Chr. Hansen employees running iLabber began in March 2011 and the final decision for global deployment was made in August. The system is currently deployed to 300 users.As part of the pilot study, Chr. Hansen has successfully integrated iLabber with several critical internal systems, including project portfolio and SAP systems, improving quality, consistency and transparency of documentation enterprise-wide. iLabber is available as both an on-premise, server-based installation and a cloud-based Software-as-a-Service offering. Both systems are well-suited for R&D organizations requiring high-quality documentation and efficient sharing of experimental work along with rapid deployment and cost-effective operation. For more information on iLabber and other organizations using iLabber solutions, visit www.ilabber.com. About Accelrys, Inc. Accelrys (NASDAQ:ACCL), a leading scientific enterprise R&D software and services company, supports industries and organizations that rely on science as a differentiator. Accelrys’ Enterprise Research & Development Architecture, built on the industry-leading Pipeline Pilot™ platform, provides a broad, flexible scientific solution optimized to integrate the diversity of science, experimental processes and information requirements across the research, development, process scale-up and early manufacturing phases of product development. Through its Enterprise R&D Architecture and market-leading electronic laboratory notebooks (ELNs), Accelrys enables scientific innovators to access, organize, analyze and share data in unprecedented ways, enhancing innovation, improving productivity and compliance, reducing costs and speeding time from lab to market.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV